An engineered bi-function fusion protein (CD86-Fc-NKG2a) to reverse NK cell tolerance of malignant cells

被引:0
|
作者
Shuptrine, Casey [1 ]
Schreiber, Taylor [1 ]
机构
[1] Shattuck Labs Inc, Durham, NC USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P810
引用
收藏
页数:2
相关论文
共 16 条
  • [1] A Fc-Engineered RANK-Fc Fusion Protein Neutralizes Soluble RANK Ligand and Targets Malignant Hematopoietic Cells for NK Cell Reactivity
    Schmiedel, Benjamin J.
    Baessler, Tina
    Scheible, Carolin
    Wende, Constantin M.
    Azuma, Miyuki
    Schneider, Pascal
    Kanz, Lothar
    Grosse-Hovest, Ludger
    Salih, Helmut R.
    BLOOD, 2009, 114 (22) : 171 - 171
  • [2] Induction of NK Cell Reactivity in Breast Cancer by Fc-Engineered NKG2D-Ig Fusion Proteins
    Raab, Stefanie
    Steinbacher, Julia
    Grosse-Hovest, Ludger
    Schmiedel, Benjamin J.
    Steinle, Alexander
    Kanz, Lothar
    Salih, Helmut R.
    BLOOD, 2012, 120 (21)
  • [3] Fc-engineered NKG2D-Ig fusion proteins for induction of NK cell ADCC against breast cancer
    Raab, S.
    Hipert, J.
    Grosse-Hovest, L.
    Schmiedel, B. J.
    Steinle, A.
    Kanz, L.
    Salih, H. R.
    ONKOLOGIE, 2012, 35 : 169 - 169
  • [4] Factor VIII moiety of recombinant Factor VIII Fc fusion protein impacts Fc effector function and CD16+ NK cell activation
    Lagasse, H. A. Daniel
    Ou, Jiayi
    Sauna, Zuben E.
    Golding, Basil
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] An Fc-optimized NKG2D-Ig fusion protein for induction of NK cell reactivity against breast cancer.
    Steinbacher, Julia
    Raab, Stefanie
    Grosse-Hovest, Ludger
    Schmiedel, Benjamin Joachim
    Steinle, Alexander
    Kanz, Lothar
    Salih, Helmut Rainer
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Fc-Engineered NKG2D-IgG1 Fusion Proteins Target Leukemia Cells for Antibody-Dependent Cellular Cytotoxicity (ADCC) of NK Cells
    Hilpert, Julia
    Baltz-Ghahremanpour, Katrin
    Schmiedel, Benjamin J.
    Kanz, Lothar
    Jung, Gundram
    Grosse-Hovest, Ludger
    Salih, Helmut R.
    BLOOD, 2011, 118 (21) : 668 - 668
  • [7] Factor VIII light chain domains of recombinant Factor VIII Fc fusion protein impact Fc effector function and CD16+NK cell activation
    Golding, Basil
    Lagasse, Daniel
    Sauna, Zuben
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [8] Induction of NK and T Cell Immune Responses Against Leukemia Cells By Bispecific NKG2D-CD16 and-CD3 Fusion Proteins
    Koerner, Samuel
    Kanz, Lothar
    Grosse-Hovest, Ludger
    Jung, Gundram
    Salih, Helmut R.
    BLOOD, 2015, 126 (23)
  • [9] Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+NK cells
    Konjevic, Gordana
    Martinovic, Katarina Mirjacic
    Jurisic, Vladimir
    Babovic, Nada
    Spuzic, Ivan
    BIOMARKERS, 2009, 14 (04) : 258 - 270
  • [10] Cutting edge:: Expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells:: A possible mechanism of tolerance during NK cell development
    Sivakumar, PV
    Gunturi, A
    Salcedo, M
    Schatzle, JD
    Lai, WC
    Kurepa, Z
    Pitcher, L
    Seaman, MS
    Lemonnier, FA
    Bennett, M
    Forman, J
    Kumar, V
    JOURNAL OF IMMUNOLOGY, 1999, 162 (12): : 6976 - 6980